AB SCIEX Opens New Asia Pacific Application and Training Centre
News Mar 12, 2012
The centre enables the scientific community in Singapore and the rest of ASEAN, Australia, New Zealand, Japan and Korea to continue its increasing use of mass spectrometry technologies for a broad range of applications. The new Singapore facility complements the regional application support centre that AB SCIEX opened last year in Shanghai, China.
This Singapore facility serves as a regional hub for the scientific community to learn about the latest innovations in analytical-based laboratory instrumentation. Its primary functions include sample analysis, instrument and workflow demonstrations, comprehensive training programs, region-specific application development, on-site and remote customer support, and scientific collaborations with research leaders in a variety of life science disciplines.
AB SCIEX has a long history of partnership throughout the life science industry within Singapore and across the Asia Pacific region. The company serves a broad range of customers in government agencies, academic research, clinical research and pharmaceutical industries.
“Leading companies such as AB SCIEX continue to play an important role in the development of Singapore’s biomedical sciences sector by providing the latest tools to advance our efforts in drug discovery research. This new centre is an excellent example of how companies can foster synergies and partnerships with the research community in Biopolis to develop innovative and region-specific solutions for Asia,” said Mr. Kevin Lai, Deputy Director, Biomedical Sciences, Singapore Economic Development Board.
“AB SCIEX continues to be a trusted partner for our customers and collaborators in Singapore and throughout the Asia Pacific region,” said Johnson Ho, Vice President of Sales, Asia-Pacific. “Our new Application and Training Centre represents our commitment to deliver world-class service and support to help our customers address critical issues, such as food safety, environmental contamination and the accuracy of clinical research results.”